Third Annual GI Cancers in Kentucky Symposium

September 13, 2025

This symposium highlights the latest clinical advances in gastrointestinal, hepatobiliary, and pancreatic cancers. Attendees will learn about recent clinical trials, new systemic therapies, advanced endoscopic techniques, high-dose radiation, and ablative therapies for metastatic disease. Additionally, they will explore cutting-edge surgical treatments such as Hepatic Artery Infusion and Liver Transplantation for advanced colorectal cancer and hepatobiliary tumors. Participants will have the opportunity to network with leading national experts in the field. This meeting is designed for oncologists, surgeons, gastroenterologists, radiologists, oncology nurses, advanced practice nurses, physician assistants, clinical oncology pharmacists, clinical research staff, cancer center administrators, program leaders, patient advocates, and medical professionals involved in cancer care, as well as students and trainees. Attendance is open to everyone, and we look forward to seeing you.  

Target Audience

This meeting is intended for oncologists, surgeons, gastroenterologists, radiologists, oncology nurses, advanced practice nurses, physician assistants, clinical oncology pharmacists, clinical research staff, cancer center administrators, cancer center program leaders, patient advocates, medical students, and trainees. Attendance is open to everyone, and we look forward to seeing you.

Learning Objectives

Upon completion of this conference, participants will be able to:

  • Analyze recent clinical trial data in gastrointestinal, hepatobiliary, and pancreatic cancers to inform evidence-based treatment decisions.
  • Evaluate the role of novel systemic therapies, advanced endoscopic approaches, and ablative techniques in managing metastatic disease.
  • Compare surgical innovations such as Hepatic Artery Infusion and Liver Transplantation for advanced colorectal and hepatobiliary cancers.
  • Discuss the application of high-dose radiation techniques in the treatment of gastrointestinal and hepatobiliary malignancies.
  • Engage with national experts and peers to exchange knowledge, foster collaboration, and strengthen professional networks in oncology care.
Course summary
Available credit: 
  • 4.75 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 4.75 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 4.75 nursing contact hour(s).

  • 4.75 Participation
    UK Healthcare CECentral certifies this activity for 4.75 hour(s) of participation.
Course opens: 
09/07/2025
Course expires: 
11/12/2025
Event starts: 
09/13/2025 - 7:00am EDT
Event ends: 
09/13/2025 - 4:00pm EDT
Add to calendar: 
Rating: 
0

Horizontal Tabs

September 13th
GI Cancers in Kentucky Welcome
Prakash Pandalai
07:00am - 07:05am
The Markey Cancer Center, Plus Q&A
Mark Evers, MD, FACS
07:05am - 07:40am
Phase I Clinical Trials in Gasto-intestinal Cancers, Plus Q&A
Meredith Pelster MD, MSCI
07:45am - 08:10am
Updates in Management of Pancreatic Cystic Neoplasms: Why, When, and How to Manage this Growing Patient Population
Ajay Maker, MD, FACS
08:15am - 08:35am
A Phase 2 Study of mRNA Vaccine Plus Immunotherapy and Chemotherapy for Operable Pancreatic Cancer, Plus Q&A
Joseph Kim, MD
08:40am - 09:05am
Keynote: Evolution of Surgical Science; How we have worked together against Gastric Cancer, Plus Keynote Discussion
Han-Kwang Yang
09:15am - 10:15am
The Role for Hepatic Artery Infusion Therapy for Unresectable Cholangiocarcinoma
Michael Cavnar, MD
10:20am - 10:35am
Hepatic Artery Infusion Therapy: What is the Role for Concurrent Chemotherapy in Patients with Hepatic Artery Infusion Therapy
Paul Helft, MD
10:40am - 11:00am
Orthotopic Liver Transplant for Colorectal Cancer: The Mayo Clinic Experience
Koji Tomiyama, MD, Ph.D
11:05am - 11:25am
Ask The Expert Panel: Unresectable Colorectal Liver Metastases
Koji Tomiyama, MD, Ph.D, Paul Helft, MD, Michael Cavnar, MD
11:30am - 11:45am
Early Onset Gastrointestinal Cancer, Plus Q&A
Mautin Barry-Hundeyin, MD
12:55pm - 01:15pm
Advanced Endoscopy in Upper GI Cancers: What Do We Do and How Do We Do It, Plus Q&A
Donald Campbell, MD
01:20pm - 01:40pm
Updates in Organ Preservation for Rectal Cancer, Plus Q&A
Jeffrey Farma MD, FACS
01:45pm - 02:10pm
Stereotactic Body Radiation for Oligometastatic Gastro-intestinal Cancers, Where, Who, How Much? , Plus Q&A
Brian Czito, MD
02:15pm - 02:40pm
Practice Changing Clinical Trials in Cholangiocarcinoma, HCC, Colorectal Liver Metastases 2020-2025, Plus Q&A
Minsig Choi, MD
02:45pm - 03:10pm
Y90 Radiation Segmentectomy for Hepatocellular Carcinoma: Evolving Evidence and Role of Systemic Therapy, Plus Q&A
Driss Raissi, MD, MBA, FSIR
03:15pm - 03:40pm
Closing Remarks
Joseph Kim, MD
03:45pm - 04:00pm

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

This live activity is designated for a maximum of 4.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CNE

The maximum number of hours awarded for this Continuing Nursing Education activity is 4.75 nursing contact hours.

Other

UK Healthcare CECentral certifies this activity for 4.75 hours of participation

Available Credit

  • 4.75 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 4.75 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 4.75 nursing contact hour(s).

  • 4.75 Participation
    UK Healthcare CECentral certifies this activity for 4.75 hour(s) of participation.
Please login or register to take this course.